AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Pretax margin (%)

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥13.4B
P/E ratio
50.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202521.6+40.96%
Mar 31, 202415.4-181.62%
Mar 31, 2023-18.8-49.96%
Mar 31, 2022-37.6-27.02%
Mar 31, 2021-51.5-56.23%
Mar 31, 2020-117.7+490.37%
Mar 31, 2019-19.9+208.44%
Mar 31, 2018-6.5-95.90%
Mar 31, 2017-157.8+1284.76%
Mar 31, 2016-11.4-40.26%
Mar 31, 2015-19.1+28.21%
Mar 31, 2014-14.9-247.98%
Mar 31, 201310.1+68.13%
Mar 31, 20126

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)